John Bencich

2022

In 2022, John Bencich earned a total compensation of $1.5M as Chief Executive Officer at OncoGenex Pharmaceuticals, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$223,125
Option Awards$358,670
Salary$510,000
Stock Awards$413,000
Total$1,504,795

Bencich received $510K in salary, accounting for 34% of the total pay in 2022.

Bencich also received $223.1K in non-equity incentive plan, $358.7K in option awards and $413K in stock awards.

Rankings

In 2022, John Bencich's compensation ranked 2,222nd out of 5,736 executives tracked by ExecPay. In other words, Bencich earned more than 61.3% of executives.

ClassificationRankingPercentile
All
2,222
out of 5,736
61st
Division
Manufacturing
1,205
out of 3,125
61st
Major group
Chemicals And Allied Products
528
out of 1,416
63rd
Industry group
Drugs
486
out of 1,317
63rd
Industry
In Vitro and In Vivo Diagnostic Substances
6
out of 29
79th
Source: SEC filing on April 28, 2023.

Bencich's colleagues

We found two more compensation records of executives who worked with John Bencich at OncoGenex Pharmaceuticals in 2022.

2022

Richard Stewart

OncoGenex Pharmaceuticals

Chairman

2022

Cindy Jacobs

OncoGenex Pharmaceuticals

Chief Medical Officer

News

You may also like